Correction to “Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide”
Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (5) : e70690
First published in Clinical and Translational Medicine. 2021;11:e495. https://doi.org/10.1002/ctm2.495
Upon recent review of figures in this paper, we found the image mislabelling error that occurred while organizing data, which resulted in the similarity between the western blot panels in Figure 3J (right) and Figure 6A. In addition, an H&E image from the shHAT1 group was inadvertently mislabelled as shHAT1+ENZ in Figure 5H during file archiving.
After carefully re-examining all original data, we confirmed that the two errors were due to the image mislabelling, and they do not affect the results and scientific conclusions of our study. However, to ensure the accuracy of the published record, we formally request the publication of the errata to correct the two figures. We sincerely apologize for this oversight and for any confusion it may have caused.
The corrected version of Figure 5H and Figure 6A is provided below.
2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |
PDF
(436KB)
